Posts Tagged ‘inhaled ribavirin’

October 30, 2012

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.


Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h02/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

RSV leads to significant morbidity in transplant patients. In lung transplants, respiratory virus infections are associated with acute rejection and bronchiolitis obliterans syndrome. Most experts treat RSV with ribavirin although the best route of ribavirin administration is unknown. In this study, the authors compare oral and inhaled routes of ribavirin administration in 21 lung transplant […]

No Comments Posted in Transplant Infectious Disease